Listed

Opus Genetics, Inc.

IRDNasdaqCIK 1228627HealthcareFiscal year ends Dec 31

Reports and events: 309 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Opus Genetics, Inc., Reports and events
FiledFormWhat it isAccession number
2022-05-1309:01 ET10-QQuarterly reportPeriod 2022-03-310001140361-22-019002
2022-05-1308:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-22-018973
2022-04-2807:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-22-016342
2022-04-2709:07 ETDEF 14AProxy statementPeriod 2022-06-130001140361-22-016115
2022-03-2908:25 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-22-011507
2022-03-2417:04 ET10-KAnnual reportPeriod 2021-12-310001140361-22-011015
2022-03-2408:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-22-010857
2022-01-3109:53 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-22-003200
2022-01-3106:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-22-003143
2022-01-0507:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-22-000594
2021-11-1517:14 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-21-037932
2021-11-1208:31 ET10-QQuarterly reportPeriod 2021-09-300001140361-21-037545
2021-08-1216:54 ET10-QQuarterly reportPeriod 2021-06-300001140361-21-028115
2021-08-1207:31 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-21-028006
2021-06-3009:17 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-21-022830
2021-06-2316:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001140361-21-022033
2021-06-0816:32 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-21-020180
2021-06-0716:05 ET8-K/A1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-21-020067
2021-06-0416:48 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-21-019927
2021-05-0716:39 ET10-QQuarterly reportPeriod 2021-03-310001140361-21-016458
2021-05-0716:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-21-016430
2021-04-2616:05 ETDEF 14AProxy statementPeriod 2021-06-070001140361-21-014256
2021-04-1216:20 ET8-K8.01 Other events0001140361-21-012441
2021-03-1509:00 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-21-008429
2021-03-1109:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-21-008135
2021-03-1108:34 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001140361-21-008130
2021-03-1121:47 ET10-KAnnual reportPeriod 2020-12-310001140361-21-008099
2021-02-0420:27 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001213900-21-006591
2021-01-0607:37 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-21-000300
2020-12-3017:13 ET8-K/A9.01 Financial statements and exhibits0001140361-20-029928
2020-11-2516:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity0001140361-20-026607
2020-11-1716:44 ET8-K5.02 Departure or appointment of officers or directors0001140361-20-025827
2020-11-0609:18 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 9.01 Financial statements and exhibits0001140361-20-024749
2020-11-0306:06 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-20-024376
2020-10-2907:04 ET10-QQuarterly reportPeriod 2020-09-300001140361-20-024042
2020-10-0916:03 ET8-K8.01 Other events0001140361-20-022798
2020-09-1106:45 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001140361-20-020176
2020-09-0207:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001140361-20-019615
2020-08-1407:30 ET10-QQuarterly reportPeriod 2020-06-300001140361-20-018406
2020-08-0307:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001140361-20-017238
2020-07-0108:37 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001140361-20-015244
2020-06-1909:02 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-20-014267
2020-05-0707:10 ET10-QQuarterly reportPeriod 2020-03-310001140361-20-010906
2020-04-2907:01 ET10-K/AAnnual report, amendedPeriod 2019-12-310001140361-20-010048
2020-04-0906:15 ET8-K1.02 Termination of a material agreement0001140361-20-008410
2020-03-1616:30 ET8-K1.01 Entry into a material agreement0001140361-20-005875
2020-02-2116:39 ET10-KAnnual reportPeriod 2019-12-310001140361-20-003785
2020-02-1016:54 ET8-K8.01 Other events0001140361-20-002721
2019-11-0617:01 ET10-QQuarterly reportPeriod 2019-09-300001140361-19-019932
2019-08-2916:30 ET8-K5.02 Departure or appointment of officers or directors0001140361-19-015801

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 19:22 ET. Listed shows no prices and gives no investment advice.